腹膜透析患者的海藻希瓦氏菌腹膜炎
Shewanella algae Peritonitis in Patients on Peritoneal Dialysis.
作者信息
Shanmuganathan Malini, Goh Bak Leong, Lim Christopher, NorFadhlina Zakaria, Fairol Ibrahim
机构信息
Nephrology Department Hospital Serdang, Selangor, Malaysia.
Nephrology Unit, Universiti Putra Malaysia, Selangor, Malaysia
出版信息
Perit Dial Int. 2016;36(5):574-5. doi: 10.3747/pdi.2015.00287.
Abstract
Patients with peritonitis present with abdominal pain, diarrhea, fever, and turbid peritoneal dialysis (PD) fluid. Shewanella algae peritonitis has not yet been reported in PD patients in the literature. We present the first 2 cases of Shewanella algae peritonitis in PD patients. Mupirocin cream is applied on the exit site as prophylactic antibiotic therapy.
摘要
腹膜炎患者表现为腹痛、腹泻、发热以及浑浊的腹膜透析（PD）液。文献中尚未报道过海藻希瓦氏菌腹膜炎在PD患者中的病例。我们报告了首例2例PD患者发生海藻希瓦氏菌腹膜炎的病例。莫匹罗星软膏作为预防性抗生素治疗应用于出口处。
相似文献
1
Shewanella algae Peritonitis in Patients on Peritoneal Dialysis.腹膜透析患者的海藻希瓦氏菌腹膜炎
Perit Dial Int. 2016;36(5):574-5. doi: 10.3747/pdi.2015.00287.
2
Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.抗生素出口处乳膏预防腹膜透析患者出口处感染的随机双盲试验。
J Am Soc Nephrol. 2005 Feb;16(2):539-45. doi: 10.1681/ASN.2004090773. Epub 2004 Dec 29.
3
Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
Perit Dial Int. 2000 Sep-Oct;20(5):566-8.
4
5
Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.沙特腹膜透析患者腹膜透析导管感染的预防：高水平莫匹罗星耐药性的出现。
Int J Artif Organs. 2013 Jul;36(7):473-83. doi: 10.5301/ijao.5000207. Epub 2013 May 16.
6
7
Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.外用洗必泰和莫匹罗星预防新发腹膜透析患者出口处感染的比较
Perit Dial Int. 2017 May-Jun;37(3):266-272. doi: 10.3747/pdi.2016.00257. Epub 2017 Feb 9.
8
Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.局部用抗生素是否降低腹膜透析患者出口部位感染率和腹膜炎发作率？泛泰晤士河肾脏审计。
J Nephrol. 2012 Sep-Oct;25(5):819-24. doi: 10.5301/jn.5000071.
9
Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.与单独使用庆大霉素相比，交替使用莫匹罗星/庆大霉素会增加真菌性腹膜炎的风险——一项随机开放标签对照试验的结果
Perit Dial Int. 2016 May-Jun;36(3):340-6. doi: 10.3747/pdi.2015.00237. Epub 2016 Apr 4.
10
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.出口部位抗菌蜂蜜与鼻用莫匹罗星预防对腹膜透析相关腹膜炎和出口部位感染的微生物学及结局的影响：蜜罐试验的一项子研究
Perit Dial Int. 2015 Dec;35(7):712-21. doi: 10.3747/pdi.2014.00206. Epub 2015 Jul 29.
引用本文的文献
1
infection in humans: Epidemiology, clinical features and pathogenicity.人类感染：流行病学、临床特征和致病性。
Virulence. 2022 Dec;13(1):1515-1532. doi: 10.1080/21505594.2022.2117831.
2
Emerging Infections Due to spp.: A Case Series of 128 Cases Over 10 Years.由 spp. 引起的新发感染：10 年期间 128 例病例系列
Front Med (Lausanne). 2022 Apr 29;9:850938. doi: 10.3389/fmed.2022.850938. eCollection 2022.
3
The Fulminating Course of Infection Caused by : A Case Report.由……引起的感染的暴发性病程：一例报告
Infect Drug Resist. 2022 Apr 8;15:1645-1650. doi: 10.2147/IDR.S357181. eCollection 2022.
4
Gut Microbial Characterization of Melon-Headed Whales () Stranded in China.中国搁浅瓜头鲸的肠道微生物特征
Microorganisms. 2022 Mar 6;10(3):572. doi: 10.3390/microorganisms10030572.
5
Characterization of putative pathogenic isolated from ballast water.从压舱水中分离出的假定病原体的特性分析。
Vet World. 2021 Mar;14(3):678-688. doi: 10.14202/vetworld.2021.678-688. Epub 2021 Mar 19.
6
Searching for putative virulence factors in the genomes of Shewanella indica and Shewanella algae.在印度希瓦氏菌和海藻希瓦氏菌的基因组中寻找潜在的毒力因子。
Arch Microbiol. 2021 Mar;203(2):683-692. doi: 10.1007/s00203-020-02060-1. Epub 2020 Oct 10.
本文引用的文献
1
Fatal PD peritonitis, necrotizing fasciitis, and bacteremia due to Shewanella putrefaciens.由腐败希瓦氏菌引起的致死性腹膜透析相关性腹膜炎、坏死性筋膜炎和菌血症。
Perit Dial Int. 2010 Nov-Dec;30(6):667-9. doi: 10.3747/pdi.2010.00084.
2
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.在治疗海藻希瓦氏菌菌血症期间，因对碳青霉烯类药物产生耐药性而导致治疗失败。
J Clin Microbiol. 2006 Mar;44(3):1172-4. doi: 10.1128/JCM.44.3.1172-1174.2006.
3
Recurrent dialysis-associated Aeromonas hydrophila peritonitis: reports of two cases and review of the literature.复发性透析相关嗜水气单胞菌腹膜炎：两例报告及文献复习
Perit Dial Int. 2005 Sep-Oct;25(5):496-9.
4
Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics.海藻希瓦氏菌和腐败希瓦氏菌：临床及微生物学特征
Clin Microbiol Infect. 2005 May;11(5):347-52. doi: 10.1111/j.1469-0691.2005.01108.x.
5
Genetic and biochemical characterization of a chromosome-encoded carbapenem-hydrolyzing ambler class D beta-lactamase from Shewanella algae.来自海藻希瓦氏菌的一种染色体编码的碳青霉烯水解性安布勒D类β-内酰胺酶的遗传和生化特性分析
Antimicrob Agents Chemother. 2004 May;48(5):1670-5. doi: 10.1128/AAC.48.5.1670-1675.2004.
6
CAPD, swimming in Shewanella.连续性 ambulatory 腹膜透析，希瓦氏菌中的游动现象
Nephrol Dial Transplant. 2000 Sep;15(9):1484-5. doi: 10.1093/ndt/15.9.1484.
7
Biochemical and pathogenic properties of Shewanella alga and Shewanella putrefaciens.海藻希瓦氏菌和腐败希瓦氏菌的生化及致病特性
J Clin Microbiol. 1998 Mar;36(3):783-7. doi: 10.1128/JCM.36.3.783-787.1998.
8
Taxonomy of four marine bacterial strains that produce tetrodotoxin.四种产生河豚毒素的海洋细菌菌株的分类学
Int J Syst Bacteriol. 1990 Oct;40(4):331-6. doi: 10.1099/00207713-40-4-331.
9
Peritonitis caused by Pseudomonas putrefaciens in patients undergoing continuous ambulatory peritoneal dialysis.在持续性非卧床腹膜透析患者中由腐败假单胞菌引起的腹膜炎。
Clin Infect Dis. 1992 Jan;14(1):359-60. doi: 10.1093/clinids/14.1.359.
10
Isolation and characterization of Shewanella alga from human clinical specimens and emendation of the description of S. alga Simidu et al., 1990, 335.从人类临床标本中分离和鉴定海藻希瓦氏菌并对1990年Simidu等人描述的海藻希瓦氏菌进行修订，335页。
Int J Syst Bacteriol. 1992 Oct;42(4):628-34. doi: 10.1099/00207713-42-4-628.
Zotero 插件